BR112013018527A2 - compostos analgésicos, métodos e formulações - Google Patents

compostos analgésicos, métodos e formulações

Info

Publication number
BR112013018527A2
BR112013018527A2 BR112013018527A BR112013018527A BR112013018527A2 BR 112013018527 A2 BR112013018527 A2 BR 112013018527A2 BR 112013018527 A BR112013018527 A BR 112013018527A BR 112013018527 A BR112013018527 A BR 112013018527A BR 112013018527 A2 BR112013018527 A2 BR 112013018527A2
Authority
BR
Brazil
Prior art keywords
methods
formulations
analgesic compounds
compounds
analgesic
Prior art date
Application number
BR112013018527A
Other languages
English (en)
Other versions
BR112013018527B1 (pt
Inventor
Jean Marie Defauw
Lun Lu
Scott Dale Holmstrom
Shuhul Chen
Wentao Wu
Xian Peng
Yang Zhang
Yujuan Ma
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR112013018527A2 publication Critical patent/BR112013018527A2/pt
Publication of BR112013018527B1 publication Critical patent/BR112013018527B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C219/30—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/20—All rings being cycloaliphatic the ring system containing seven carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/50—Spiro compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

compostos analgésicos, métodos e formulações a presente invenção refere-se a compostos analgésicos e a sais dos mesmos, de fórmula l: em que a é a adicionalmente, são fornecidos formulações farmacêticas e métodos de uso empregando os compostos acima.
BR112013018527-9A 2011-01-27 2012-01-13 Compostos analgésicos, e formulação farmacêutica BR112013018527B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2011/070706 2011-01-27
PCT/CN2011/070706 WO2012100423A1 (en) 2011-01-27 2011-01-27 Analgesic compounds, methods, and formulations
PCT/US2012/021181 WO2012102875A2 (en) 2011-01-27 2012-01-13 Analgesic compounds, methods, and formulations

Publications (2)

Publication Number Publication Date
BR112013018527A2 true BR112013018527A2 (pt) 2016-10-18
BR112013018527B1 BR112013018527B1 (pt) 2021-11-09

Family

ID=45558412

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013018527-9A BR112013018527B1 (pt) 2011-01-27 2012-01-13 Compostos analgésicos, e formulação farmacêutica

Country Status (22)

Country Link
US (1) US8802728B2 (pt)
EP (1) EP2668152B1 (pt)
JP (1) JP6002153B2 (pt)
KR (1) KR101612168B1 (pt)
CN (2) CN103328433B (pt)
AR (2) AR084815A1 (pt)
AU (1) AU2012209430B2 (pt)
BR (1) BR112013018527B1 (pt)
CA (1) CA2825816C (pt)
CL (1) CL2013002102A1 (pt)
CO (1) CO6781505A2 (pt)
EA (1) EA024101B1 (pt)
ES (1) ES2612495T3 (pt)
IL (1) IL227250A (pt)
IN (1) IN2013MN01164A (pt)
MX (1) MX345518B (pt)
MY (1) MY163262A (pt)
SG (1) SG192131A1 (pt)
TW (1) TWI564275B (pt)
UA (1) UA110122C2 (pt)
WO (2) WO2012100423A1 (pt)
ZA (1) ZA201304786B (pt)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
DE1518663A1 (de) * 1965-08-02 1969-12-18 Gruenenthal Chemie Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
DE19547766A1 (de) * 1995-12-20 1997-06-26 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe
DE19805370A1 (de) * 1997-03-14 1998-09-17 Gruenenthal Gmbh Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen
ES2141688B1 (es) * 1998-11-06 2001-02-01 Vita Invest Sa Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
DE10049481A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte C-Cyclohexylmethylamin-Derivate
AU2002364517A1 (en) * 2001-11-30 2003-06-17 Sepracor Inc. Tramadol analogs and uses thereof
DE10233048A1 (de) * 2002-07-19 2004-01-29 Grünenthal GmbH Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken
US20050182131A1 (en) 2002-07-19 2005-08-18 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
EP2022778A1 (en) 2007-08-07 2009-02-11 Laboratorios del Dr. Esteve S.A. A crystalline form of (R,R)-tramadol-(S)-naproxene salt

Also Published As

Publication number Publication date
JP6002153B2 (ja) 2016-10-05
CA2825816A1 (en) 2012-08-02
IN2013MN01164A (pt) 2015-04-17
US20130225679A1 (en) 2013-08-29
EA024101B1 (ru) 2016-08-31
KR20130116348A (ko) 2013-10-23
ES2612495T3 (es) 2017-05-17
WO2012100423A1 (en) 2012-08-02
CN105753723A (zh) 2016-07-13
CN105753723B (zh) 2018-11-06
TW201242930A (en) 2012-11-01
MY163262A (en) 2017-08-30
AR126189A2 (es) 2023-09-27
CL2013002102A1 (es) 2014-06-27
CO6781505A2 (es) 2013-10-31
EA201390857A1 (ru) 2014-01-30
MX2013008708A (es) 2014-01-23
NZ612731A (en) 2015-04-24
AU2012209430A1 (en) 2013-07-04
WO2012102875A3 (en) 2012-10-18
AR084815A1 (es) 2013-06-26
KR101612168B1 (ko) 2016-04-12
SG192131A1 (en) 2013-08-30
CN103328433B (zh) 2016-06-08
BR112013018527B1 (pt) 2021-11-09
US8802728B2 (en) 2014-08-12
CN103328433A (zh) 2013-09-25
TWI564275B (zh) 2017-01-01
IL227250A (en) 2015-03-31
UA110122C2 (uk) 2015-11-25
CA2825816C (en) 2016-08-09
EP2668152B1 (en) 2016-10-12
MX345518B (es) 2017-02-02
WO2012102875A2 (en) 2012-08-02
ZA201304786B (en) 2014-12-23
AU2012209430B2 (en) 2014-11-13
EP2668152A2 (en) 2013-12-04
JP2014511368A (ja) 2014-05-15

Similar Documents

Publication Publication Date Title
CY1121418T1 (el) Παρεμποδιστες ιου ηπατιτιδας c
BR112015022077A2 (pt) composto de pirazol-amida e usos medicinais do mesmo
RS54873B1 (sr) Policiklična-karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba
CR20140519A (es) Derivados de benzamida para la inhibición de la actividad de abl 1, abl 2 y bcr-abl 1
EA201300200A1 (ru) N-((6-аминопиридин-3-ил)метил)гетероарилкарбоксамиды в качестве ингибиторов калликреина в плазме
BR112013031405A2 (pt) piridopirazinas substituídas como novos inibidores de syk
BR112015000561A2 (pt) inibidores de irak e usos dos mesmos
BR112015021983A2 (pt) compostos heterocíclicos e usos dos mesmos
BR112016010080A8 (pt) compostos de pirazolopirimidina, composição farmacêutica e seu uso
BR112015002821A8 (pt) compostos inibidores de neprilisina, composição farmacêutica e uso dos compostos
BR112012017382A2 (pt) compostos inibidores de viroses flaviviridae, uso dos mesmos e composição farmacêutica
BR112016011755A2 (pt) derivado de ureia ou sal farmacologicamente aceitável do mesmo
EA201492287A1 (ru) Дейтерированные производные руксолитиниба
RS54526B1 (en) USE OF PIRAZOLOSPIROKETONE DERIVATIVES AS ACETYL-COA CARBOXYLASE INHIBITORS
BR112015007310A2 (pt) compostos, composição farmacêutica, uso de um composto de fórmula (i) e uso de uma composição farmacêutica
BR112015012825A2 (pt) piridopirazinas substituídas como inibidores de syk
EA201491820A1 (ru) Новые тиенопиримидиновые производные, способы их получения и их терапевтические применения
TR201902057T4 (tr) Tetrasiklin bileşikleri.
BRPI1014802B8 (pt) profármacos de triptolida.
BR112014026305A2 (pt) derivado de quinazolidinadiona
BR112015020222A2 (pt) compostos de azetidiniloxifenilpirrolidina
BR112015021768A2 (pt) inibidores do vírus da hepatite c
AU2016204294A1 (en) Solid State Forms Of A Quinazoline Derivative And Its Use As A BRAF Inhibitor
BR112013027395A2 (pt) inibidores de 17alfa-hidroxilase/c17,20-liase
BR112013022710A2 (pt) derivado de azol

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: ELANCO US INC. (US)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/01/2012, OBSERVADAS AS CONDICOES LEGAIS.